Steve Fife CEO – LifeVantage(Nasdaq: LFVN), a leading health and wellness company, has announced the acquisition of LoveBiome, a pioneering direct sales company dedicated to microbiome care. This strategic acquisition strengthens LifeVantage’s position in the rapidly growing microbiome health sector and enhances its innovative product lineup.
LoveBiome has established itself as a leader in microbiome health, with its flagship P84 product designed to regulate, repair, and restore gut health. Understanding the crucial connection between gut health and overall wellness, LoveBiome’s solutions activate the body’s natural processes, further complementing LifeVantage’s core Activation philosophy. The acquisition brings LoveBiome’s cutting-edge expertise into LifeVantage’s diverse product portfolio, which includes scientifically validated products like the Protandim® family and MindBody GLP-1 System™.
“This acquisition aligns perfectly with our mission to offer a better path to wellness and a vibrant life for people globally,” said Steve Fife, President and CEO of LifeVantage. “By combining LoveBiome’s microbiome solutions with our proven activation technologies, we can activate wellness—both physical and financial—for a broader consumer base.”
With this acquisition, LifeVantage will now expand its influence in key markets, including Taiwan, Europe, and the United States, bolstering its Consultant network and global reach.
The microbiome health industry is witnessing rapid growth. The global market for gut health supplements is expected to grow from $14.4 billion in 2025 to $32.4 billion by 2035, with a robust annual growth rate of 8.4%. This acquisition positions LifeVantage to tap into this lucrative market, enhancing revenue growth and accelerating long-term profitability.
Under the terms of the acquisition, LifeVantage will acquire LoveBiome’s critical operating assets, which include essential personnel and their expertise in direct sales. The acquisition will help retain LoveBiome’s founder, Kelly Olsen, and his team, ensuring a smooth integration and continued innovation in microbiome solutions. The transaction is expected to close by mid-October, subject to regulatory approvals.
LifeVantage’s pioneering products, such as the Protandim® line, TrueScience® Liquid Collagen, and AXIO® nootropic energy drinks, will be further complemented by the microbiome health expertise brought in by LoveBiome. With a unique approach to activating health processes at the cellular level, LifeVantage remains a leader in nutrigenomics and wellness innovation.
Founded in 2003, LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, helping people unlock their health potential through scientifically validated products. LifeVantage’s unique line of products, including the Protandim® family, TrueScience® skin care, and Petandim® for pets, work to activate the body’s natural processes to support wellness.
Get more information
There are no reviews yet. Be the first one to write one.
